Baohong W. Zhang - Publications

Transition Radiation Field Enhanced Laser Proton Acceleration Employing Near-Critical-Density Foam.

Journal: Nature communications

Published: August 04, 2025

Establishing clinically relevant dissolution specifications for prodrug bioequivalence risk assessment: Integration of a dissolution/permeation system with physiologically based biopharmaceutics modeling in abiraterone acetate.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: May 27, 2025

Numerical study on hydrodynamic characteristics of USP apparatus 3 using CFD method.

Journal: International journal of pharmaceutics

Published: April 09, 2025

Rapid restoration of potent neutralization activity against the latest Omicron variant JN.1 via AI rational design and antibody engineering.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: February 05, 2025

Generating potent and persistent antitumor immunity via affinity-tuned CAR-T cells targeting mesothelin.

Journal: Acta pharmacologica Sinica

Published: January 01, 2025

Enhance therapeutic efficacy of BiTE (HER2/CD3) for HER2- positive tumors through in vivo expression.

Journal: International journal of pharmaceutics: X

Published: December 03, 2024

A novel ROR1-targeting antibody-PROTAC conjugate promotes BRD4 degradation for solid tumor treatment.

Journal: Theranostics

Published: August 19, 2024

Establishment of Biopredictive Dissolution and Bioequivalence Safe Space Using the Physiologically Based Biopharmaceutics Modeling for Tacrolimus Extended-Release Capsules.

Journal: AAPS PharmSciTech

Published: July 28, 2024

Supramolecular antibody-drug conjugates for combined antibody therapy and photothermal therapy targeting HER2-positive cancers.

Journal: International journal of biological macromolecules

Published: April 26, 2024

Assessment of Single-Cycle M-Protein Mutated Vesicular Stomatitis Virus as a Safe and Immunogenic Mucosal Vaccine Platform for SARS-CoV-2 Immunogen Delivery.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: April 20, 2024

The immunotoxin targeting PRLR increases tamoxifen sensitivity and enhances the efficacy of chemotherapy in breast cancer.

Journal: Journal of experimental & clinical cancer research : CR

Published: March 26, 2024

Characterization of a novel T cell-engaging bispecific antibody for elimination of L1CAM-positive tumors.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: December 31, 2023